Drug safety evaluation of aripiprazole in bipolar disorder-Reference-Cited by-同舟云学术

Drug safety evaluation of aripiprazole in bipolar disorder

Published:2019-05-17 Issue:6 Volume:18 Page:455-463
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Cuomo Alessandro¹²,Beccarini Crescenzi Bruno¹,Goracci Arianna¹,Bolognesi Simone¹,Giordano Nicola³,Rossi Rodolfo⁴⁵,Facchi Edvige⁶,Neal Stephen M⁷,Fagiolini Andrea¹

Affiliation:

1. Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy

2. Department of Mental Health and Addiction Services, ASST Lombardy Health Care System, Carlo Poma Hospital, Mantova, Italy

3. Department of Medicine, Surgical and Neurological Sciences, University of Siena, Siena, Italy

4. Department of System Medicine (RR), Tor Vergata University, Rome, Italy

5. Department of Mental Health & Drug Abuse, AUSL Modena, Modena, Italy

6. Department of Mental Health, USL Toscana Sud East (EF), Siena, Italy

7. Department of Psychiatry, West Virginia School of Osteopathic Medicine, Lewisburg, WV, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2019.1617847

Reference76 articles.

1. Prevalence, chronicity, burden and borders of bipolar disorder

2. Burden of general medical conditions among individuals with bipolar disorder

3. Health and Economic Burden of Metabolic Comorbidity Among Individuals With Bipolar Disorder

4. Comorbidity in bipolar disorder: a framework for rational treatment selection

5. Current issues in bipolar disorder: A critical review

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Neuropsychiatric Drugs on the Oxidation-Reduction Balance in Therapy;International Journal of Molecular Sciences;2024-07-03

2. Impact of Preoperative Aripiprazole on Postoperative Analgesia in Laparoscopic Hysterectomy;The Clinical Journal of Pain;2024-03-07

3. Evaluating the efficacy and safety of the currently available once-every-two months long-acting injectable formulations of aripiprazole for the treatment of schizophrenia or as a maintenance monotherapy for bipolar I disorder in adults;Expert Review of Neurotherapeutics;2024-02-05

4. Novel bioequivalent oral disintegrating tablet of aripiprazole prepared by direct compression technique with shortened disintegration time;Pharmaceutical Development and Technology;2024-01-02

5. Assessment and Management of Agitation;Tasman’s Psychiatry;2024